| Literature DB >> 36105199 |
Yingxue Guo1,2, Yan Qu1,3, Wenpeng Li4, Hongkuan Shen5, Jiwen Cui2, Jiguang Liu1,4, Jinlian Li2, Dongmei Wu2.
Abstract
The aging process of human beings is accompanied by the decline of learning and memory ability and progressive decline of brain function, which induces Alzheimer's Disease (AD) in serious cases and seriously affects the quality of patient's life. In recent years, more and more studies have found that natural plant antioxidants can help to improve the learning and memory impairment, reduce oxidative stress injury and aging lesions in tissues. This study aimed to investigate the effect of Monarda didymaL. essential oil and its main component thymol on learning and memory impairment in D-galactose-induced aging mice and its molecular mechanism. The composition of Monarda didymaL. essential oil was analyzed by Gas Chromatography-Mass Spectrometer (GC-MS). A mouse aging model was established by the subcutaneous injection of D-galactose in mice. The behavior changes of the mice were observed by feeding the model mice with essential oil, thymol and donepezil, and the histopathological changes of the hippocampus were observed by HE staining. And the changes of acetylcholinesterase (AchE), superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) activities, and the content of malondialdehyde (MDA) in hippocampal tissues were detected by corresponding kits. The expression of mitogen activated protein kinase (MAPK) and nuclear factor E2 related factor 2 (Nrf2) pathways related proteins were detected by western blot. Animal experimental results showed that compared with model group, the above indexes in Monarda didymaL. essential oil and thymol groups improved significantly in a dose-dependent manner. Monarda didymaL. essential oil and its main active component thymol can improve the learning and memory impairment of aging mice to some extent, and Nrf2 and MAPK pathways may be involved in its action process.Entities:
Keywords: Monarda didymaL. essential oil; Nrf2/HO-1 and MAPK pathways; Thymol; aging; learning and memory impairment
Year: 2022 PMID: 36105199 PMCID: PMC9464920 DOI: 10.3389/fphar.2022.992269
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
Composition of Monarda didymaL. essential oil.
| Peak | Compounds | Peak area (%) | Retention time (min) |
|---|---|---|---|
| 1 | b-Thugene | 3.62 | 6.51 |
| 2 | α-Pinene | 0.55% | 6.67 |
| 3 | Myrcene | 1.63% | 7.77 |
| 4 |
| 2.89% | 8.54 |
| 5 | o-Cymene | 11.0% | 8.76 |
| 6 | γ-Terpinene | 16.6% | 9.79 |
| 7 | Thymol | 63.8% | 17.86 |
FIGURE 1Comparison of water maze test results of mice in each group. (A) Comparison of escape latency of mice in plateau stage; (B) Comparison of average swimming speed of mice in the plateau stage; (C) Comparative analysis of escape latency of mice in hiding plateau stage; (D) Comparison of the number of times of mice crossing the platform in non-platform stage; (E) Comparison of platform quadrant activity time between groups in non-platform phase; Compared with control group *p < 0.05; Compared with model group #p < 0.05; compared with donepezil group &p < 0.05 n = 10.
FIGURE 2Comparison of step-through test of mice in each group. (A) Comparison of escape latency; (B) Comparison of error times; Compared with control group *p < 0.05; compared with model group #p < 0.05; compared with donepezil group &p < 0.05 n = 10.
FIGURE 3Pathological observation in hippocampal tissues of mice in each group (HE staining). (A) Control group; (B) model group; (C) donepezil group; (D) oil-L group; (E) oil-M group; (F) oil-H group; (G) thymol-L group; (H) thymol-M group; (I) thymol-H group. The scale is 50 μm.
Comparison of oxidative stress indexes and AchE activity in each group (n = 5).
| Group | SOD (U/mg) | GSH-Px (U/mg) | MDA (nmol/mg) | AchE (U/mg) |
|---|---|---|---|---|
| control | 276.33 ± 12.89 | 236.78 ± 15.53 | 6.52 ± 0.80 | 0.41 ± 0.01 |
| model | 132.28 ± 6.77* | 105.85 ± 9.36* | 18.35 ± 1.89* | 0.58 ± 0.08* |
| donepezil | 271.45 ± 13.49# | 229.57 ± 12.64# | 6.24 ± 1.15# | 0.42 ± 0.02# |
| oil-L | 145.46 ± 8.93#& | 137.62 ± 8.69#& | 17.65 ± 2.03#& | 0.54 ± 0.03& |
| oil-M | 189.35 ± 11.28#& | 159.35 ± 9.04#& | 12.49 ± 1.25#& | 0.50 ± 0.03#& |
| oil-H | 256.23 ± 14.71# | 210.81 ± 12.37# | 6.89 ± 0.95# | 0.45 ± 0.03# |
| thymol-L | 174.52 ± 9.05#& | 147.38 ± 8.66#& | 14.60 ± 1.11#& | 0.52 ± 0.03#& |
| thymol-M | 234.64 ± 10.48#& | 185.15 ± 9.34#& | 10.36 ± 1.05#& | 0.46 ± 0.02#& |
| thymol-H | 263.18 ± 12.54# | 227.04 ± 13.67# | 5.97 ± 0.50# | 0.41 ± 0.02# |
Note: compared with control *p < 0.05; compared with model #p < 0.05; compared with donepezil and p < 0.05.
FIGURE 4Comparison of related proteins expression levels in each group. Compared with control group *p < 0.05; Compared with model group #p<0.05; compared with donepezil group &p < 0.05 n = 10.